USA. McKinsey akzeptiert in Opioidkrise millionenschweren Vergleich Washington – Im Streit um die massenhafte Verschreibung opioidhaltiger Schmerzmittel in den USA hat das Beratungsunternehmen McKinsey Medienberichten zufolge in einen millionenschw…

Betrug & Todesfälle: Geschichte und Lehren der 2. US-amerikanischen Opioid-Epidemie Michael Klein, addiction.de, 14.01.2021 https://www.addiction.de/us-amerikanische-opioid-epidemie/

USA. Biden Is Opposing a Promising Step Toward Buprenorphine Deregulation In the final week of former President Trump’s term, the US Department of Health and Human services (HHS) announced a practice guideline that would exempt physicians from the…

USA. Biden moving to nix Trump plan on opioid-treatment prescriptions The plan had been hailed by many physicians as loosening requirements they said slowed their response to the opioid crisis. But legal experts said HHS lacked authority to is…

EMCDDA. EMCDDA enters new phase as it embarks on 2021 activities  This year, the EMCDDA will embark on a new five-year Roadmap under its Strategy 2025, kicking off with an ambitious range of activities for the period 2021–23. We enter this new…

Commentary on Furr‐Holden et al. (2020): Drugs, class, and race—recent developments in the opioid epidemic call for urgent next steps.  Caputi, T. L. (2020)  Addiction, doi.org/10.1111/add.15339 https://onlinelibrary.wiley.com/doi/10.11…